FDA OKs Givinostat for Duchenne Muscular Dystrophy FDA OKs Givinostat for Duchenne Muscular Dystrophy
Givinostat (Duvyzat), a histone deacetylase inhibitor, is the first nonsteroidal drug approved to treat patients aged 6 years or older with all genetic variants of DMD.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery Source Type: news
More News: Brain | Genetics | Muscular Dystrophy | Neurology | Neurosurgery | Reflex Sympathetic Dystrophy